Google
Trusted Resources: News & Events
Latest announcements and gatherings
SCDAA Masterclass Speaker Series: All Things Considered – SCD Treatment: A Personal Choice
SCDAA’s First Masterclass on the Cusp of a Cure
All Things Considered – SCD Treatment: A Personal Choice
Thursday, August 24, 2023 at 3-4 p.m. EST
Co-hosts Teonna Woolford and Dr. Wanda Whitten-Shurney will discuss the many considerations that go into choosing disease modifying treatments or curative therapies. Panelists include speakers who will share their lived SCD experiences, the choices they made, and why.
+myBinderRelated Content
-
Sancilio Pharmaceuticals Company announces Altemia™ receives orphan drug designation from the European Medicines A...Sancilio Pharmaceuticals Company, Inc. (...
-
2019 Annual Sickle Cell Symposium – Sickle Cell: Past Present and FutureDRAFT Agenda 5:00pm Registration, netwo...
-
SCA Therapy Hydroxyurea Doesn’t Boost Malaria Risk in Sub-Saharan Africa, Study FindsHydroxyurea, a treatment recommended for...
-
Assessing the safety and efficacy of converting adults with sickle cell disease from full agonist opioids to bupreno...Background: The management of pain in ad...
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseBackground: Deoxygenated sickle hemog...
-
Sickle Cell Disease Research Shows Progress in Preventing Related Complications and DeathStudies aim to limit pain crises, preven...
-
Oxygen’s surprisingly complex journey through your body – Enda Butlerhttps://www.youtube.com/watch?v=GVU_zANt...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.